Skip to main content
. 2021 Aug 12;6(33):21384–21394. doi: 10.1021/acsomega.1c02175

Figure 6.

Figure 6

Effect of SP, PSP-1, and PSP-2 on RAW 264.7 cells. Effects of SP, PSP-1, and PSP-2 treatment cells at different concentrations (100, 200, 400, 1000, and 2000 μg/mL) on the viability of RAW 264.7 cells (A). Phagocytic capacity of RAW 264.7 cells pretreated with SP, PSP-1, and PSP-2 (B). NO production of RAW 264.7 cells pretreated with SP, PSP-1, and PSP-2 (C). Relative expression of iNOS in RAW 264.7 cells treated with SP, PSP-1, and PSP-2 (D). Gene expression levels of IL-6 cytokines in RAW 264.7 cells treated with SP, PSP-1, and PSP-2 (E). Cells were cultured with different concentrations (100, 200, 400, and 1000 mg/mL) of SP, PSP-1, and PSP-2 for 24 h. LPS (2 μg/mL) was used as a positive control. *p < 0.05 and **p < 0.01 compared with the control group (0 mg/mL), n = 6.